Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This study aims to determine if a strategy of recommending prone (on stomach) positioning of patients positive or suspected positive for coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, but not mechanically ventilated, Is feasible in the inpatient setting. This study will be performed as a pragmatic pilot clinical trial to gain information relevant to the future conduct of a larger trial.
Description: Average oxygen saturation to fraction of inspired oxygen ratio
Measure: Average S/F ratio Time: 48 hours from eligibilityDescription: Time spent with oxygenation saturation to fraction of inspired oxygen ratio less than 315
Measure: Time spent with S/F ratio < 315 Time: 48 hours from eligibilityDescription: Highest level of supplemental oxygen required
Measure: Highest oxygen support Time: 48 hours from eligibilityDescription: Number of patients requiring ICU admission during study period
Measure: Number of patients requiring ICU admission during study period Time: 48 hours from eligibilityDescription: Number of patients requiring ICU admission during hospitalization
Measure: Number of patients requiring ICU admission during hospitalization Time: through study completion, Up to 30 daysDescription: Number of patients who die prior to hospital discharge
Measure: Number of patients experiencing who die prior to discharge Time: through study completion, Up to 30 daysDescription: Number of patients requiring intubation
Measure: Number of patients requiring intubation Time: 48 hours From eligibilityDescription: Number of days from hospital admission to discharge
Measure: Hospital length of stay Time: through study completion, Up to 30 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports